{"id":"NCT01747330","sponsor":"Abbott Products","briefTitle":"Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency","officialTitle":"An Open Label, Multicenter Study Evaluating Safety and Tolerability of Creon Micro in Pediatric Subjects From at Least One Month to Less Than Four Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06","primaryCompletion":"2012-12","completion":"2012-12","firstPosted":"2012-12-11","resultsPosted":"2014-07-15","lastUpdate":"2014-07-15"},"enrollment":40,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pancreatic Exocrine Insufficiency"],"interventions":[{"type":"DRUG","name":"Pancreatin","otherNames":["Creon micro"]}],"arms":[{"label":"Creon micro, minimicrospheres","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and tolerability of Creon micro in children younger than four years with pancreatic exocrine insufficiency.","primaryOutcome":{"measure":"Body Weight","timeFrame":"3 months","effectByArm":[{"arm":"Creon Micro, Minimicrospheres","deltaMin":0.75,"sd":0.61}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":9,"countries":["Russia"]},"refs":{"pmids":["25066363"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":["infections NEC","upper respiratory tract infections","gastrointestinal spastic and hypermotility disorders"]}}